Market Place
Sourcing Support
Medicus Pharma Constructs Three $1B Bets In Vanderbilt Report
14 Oct 2025 //
ACCESSWIRE
Medicus Pharma Ltd. To Present At The Maxim Growth Summit 2025
13 Oct 2025 //
PHARMIWEB
Medicus Pharma Receives FDA Type C Meeting Feedback For Skinject
29 Sep 2025 //
PHARMAWEB
Medicus Pharma Ltd. To Present At Brookline Capital Markets
24 Sep 2025 //
PHARMAWEB
Medicus Pharma Announces $8.0M Non-Dilutive Debenture Financing
18 Sep 2025 //
PHARMAWEB
Medicus Updates on UAE Phase 2 Study for Basal Cell Carcinoma
08 Sep 2025 //
PHARMAWEB
Medicus` Ph2 SKNJCT-003 Shows Positive Basal Cell Carcinoma Data
06 Mar 2025 //
GLOBENEWSWIRE
Medicus Submits Ph 2 Design To UAE DOH For Non-Invasive BCC Treatment
27 Feb 2025 //
GLOBENEWSWIRE
Medicus Updates Ph2 SKNJCT-003 Study In Nodular BCC Treatment
14 Feb 2025 //
GLOBENEWSWIRE
Medicus Signs Equity Deal, Plans Voluntary TSXV Delisting
11 Feb 2025 //
GLOBENEWSWIRE
Medicus Pharma Receives FDA MUMS Designation for D-MNA Patch
12 Dec 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.